IP Forecast: Fed. Circ. To Mull Arthrex's Latest USPTO Fight

By Andrew Karpan (March 24, 2022, 9:05 PM EDT) -- Arthrex will argue next week that the Federal Circuit must undo the Patent Trial and Appeal Board's invalidation of its suture patent because the patent office's interim leader lacks the power to review that ruling under a U.S. Supreme Court decision involving the company. 

The Federal Circuit is holding a special session March 30 to hear the latest legal effort by Arthrex Inc. to breathe new life into the medical device maker's patent. A panel of PTAB judges wiped the patent out in 2018 after the small Florida company landed a $17 million jury verdict against Smith & Nephew Inc. for...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!